The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen a...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in aging neuroscience Vol. 16; p. 1347987
Main Authors Adamu, Alhamdu, Li, Shuo, Gao, Fankai, Xue, Guofang
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 12.04.2024
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson’s disease, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders.
AbstractList Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson’s disease, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders.
Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson's disease, Alzheimer's, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders.Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson's disease, Alzheimer's, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders.
Author Li, Shuo
Adamu, Alhamdu
Gao, Fankai
Xue, Guofang
Author_xml – sequence: 1
  givenname: Alhamdu
  surname: Adamu
  fullname: Adamu, Alhamdu
– sequence: 2
  givenname: Shuo
  surname: Li
  fullname: Li, Shuo
– sequence: 3
  givenname: Fankai
  surname: Gao
  fullname: Gao, Fankai
– sequence: 4
  givenname: Guofang
  surname: Xue
  fullname: Xue, Guofang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38681666$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1vEzEQhi1URNvQP8ABWeLCJcFfa3u5oQpKpUpcytnyesdbRxs7tb1I_HvcJFSoB3wZa_y8M2PNe4nOYoqA0DtKNpzr_pOPdgobRpjYUC5Ur9UrdEGl5GvBZXf2z_0cXZWyJe1wTkin36BzrqVu7_ICPd4_AM5pBpw8jrDkFKKf7W5na0gRh3hMjjBBhNySvwCPoYAtUD5jt-QMseIljpBLtXEMccItYL_UJQOuD020h6UGh6vNE9TyFr32di5wdYor9PPb1_vr7-u7Hze311_u1k4IWteKetYzqYDrEUaqiRODtZ10VFHREeHUyITmuvNUc9UTaakWAgZmNYDSwFfo9lh3THZr9jnsbP5tkg3mkEh5Mja3uWYwzHHBQXrCeOsyyMF6r3vnJHXSSu1arY_HWvucHhco1exCcTDPNkJaiuFEaNGLjrGGfniBbtOSY_tpo7iifa_aHlbo_Ylahh2Mz-P9XUwD2BFwOZWSwT8jlJgnA5iDAcyTAczJAE2kX4hcqIdF1mzD_D_pHwRdt1c
CitedBy_id crossref_primary_10_1016_j_fbio_2024_105799
crossref_primary_10_1016_j_fitote_2024_106173
crossref_primary_10_3390_biomedicines12122670
crossref_primary_10_1186_s40035_024_00435_8
crossref_primary_10_1155_2024_9965893
crossref_primary_10_3390_ijms25189859
crossref_primary_10_3390_ph17101391
crossref_primary_10_3390_ijms25126488
crossref_primary_10_3724_zdxbyxb_2024_0208
crossref_primary_10_1016_j_molmed_2025_01_009
crossref_primary_10_1016_j_tice_2025_102725
crossref_primary_10_26599_NBE_2024_9290099
crossref_primary_10_1097_WCO_0000000000001352
crossref_primary_10_3389_fphar_2025_1540736
crossref_primary_10_1111_cen3_12830
crossref_primary_10_1007_s00702_025_02902_6
crossref_primary_10_1016_j_arr_2024_102450
crossref_primary_10_1016_j_bbr_2025_115510
crossref_primary_10_1016_j_jddst_2024_106413
crossref_primary_10_3390_ijms252312701
crossref_primary_10_3390_neuroglia5040027
crossref_primary_10_3390_ijms252212164
crossref_primary_10_3390_ijms25179588
crossref_primary_10_1007_s12017_025_08843_3
crossref_primary_10_1007_s00204_024_03903_2
crossref_primary_10_22159_ijap_2025v17i2_53425
crossref_primary_10_3389_fphar_2025_1492517
crossref_primary_10_1007_s00210_024_03515_8
crossref_primary_10_1186_s43066_024_00386_9
crossref_primary_10_3390_ijms252312613
crossref_primary_10_59324_ejeba_2024_1_3__08
crossref_primary_10_1016_j_aehs_2025_02_002
crossref_primary_10_3389_fcimb_2024_1421571
crossref_primary_10_3390_cimb47010008
crossref_primary_10_3390_jpm14111081
crossref_primary_10_4103_ed_ed_16_24
crossref_primary_10_3390_jcm14020386
crossref_primary_10_3390_ijms252413614
crossref_primary_10_3390_antiox13121462
crossref_primary_10_1007_s12035_025_04808_6
crossref_primary_10_1186_s13148_025_01820_4
crossref_primary_10_32604_biocell_2024_058405
crossref_primary_10_3390_microorganisms13010090
crossref_primary_10_3390_ijms25115973
crossref_primary_10_1016_j_biopha_2025_117905
crossref_primary_10_37349_ent_2025_100498
crossref_primary_10_1039_D4RA07798A
crossref_primary_10_1111_cns_70053
crossref_primary_10_3390_cimb47020096
crossref_primary_10_3390_ijms25179747
crossref_primary_10_1038_s41538_025_00378_y
crossref_primary_10_37349_en_2025_100673
crossref_primary_10_2147_DDDT_S507697
crossref_primary_10_3390_biomedicines12081894
crossref_primary_10_1089_neur_2024_0116
crossref_primary_10_1155_adpp_2869332
crossref_primary_10_1016_j_dscb_2025_100193
crossref_primary_10_1016_j_arr_2024_102544
crossref_primary_10_3390_antiox13111354
crossref_primary_10_3390_nu17030558
crossref_primary_10_3390_biology13121030
crossref_primary_10_1016_j_ejmech_2024_116763
crossref_primary_10_1073_pnas_2410996121
crossref_primary_10_3390_ijms252111638
crossref_primary_10_3390_ijms25137115
crossref_primary_10_3390_biomedicines12112514
Cites_doi 10.3892/ijo.2021.5275
10.1517/17425255.4.10.1265
10.4103/0019-5545.44908
10.3389/fncel.2021.749587
10.1007/s13311-022-01247-2
10.3390/cells12101368
10.3390/sci3010012
10.1186/s40035-020-00221-2
10.1016/j.nbd.2020.104963
10.3389/fnagi.2022.872134
10.3389/fncel.2017.00216
10.1523/JNEUROSCI.23-05-01605.2003
10.1177/1352458520970841
10.3389/fnagi.2021.782082
10.1177/1179573517709278
10.1038/s41392-023-01486-5
10.1101/cshperspect.a009399
10.1016/j.it.2020.07.007
10.1155/2021/8874339
10.2147/IJN.S35333
10.1097/AIA.0b013e318034194e
10.1021/acsomega.3c04862
10.3390/ijms22063027
10.1177/03000605231177191
10.1080/14728222.2018.1486823
10.3389/fphar.2021.643254
10.1016/j.bbamcr.2014.05.014
10.1016/j.tins.2020.10.008
10.1186/s12929-017-0355-7
10.1016/j.biopha.2020.110887
10.3390/cimb45020094
10.1016/j.apsb.2020.01.015
10.3390/cells11071139
10.3390/ijms23052400
10.1038/s41573-020-0082-8
10.3389/fcell.2019.00313
10.1016/j.heliyon.2018.e00508
10.3390/cells9071687
10.1007/s12264-023-01023-y
10.1155/2022/7924199
10.1016/j.ceb.2015.02.004
10.3390/ijms21218060
10.3389/fnins.2019.01310
10.3389/fimmu.2019.02538
10.1097/JCN.0b013e318197a6a5
10.2147/IJN.S347187
10.1146/annurev-immunol-061020-053707
10.1039/d1md00280e
10.1007/s00401-021-02384-2
10.1186/s40035-023-00392-8
10.1155/2021/7834421
10.3389/fnagi.2022.815347
10.3390/biotech11010006
10.1016/j.pharep.2018.11.005
10.7759/cureus.47861
10.3389/fnmol.2020.00148
10.3389/fneur.2021.654739
10.3390/antiox11112287
10.3389/fnins.2017.00680
10.3390/biology12101307
10.5772/67656
10.3233/JAD-215025
10.1038/s41392-023-01452-1
10.3389/fnagi.2021.636545
10.1186/s12974-021-02114-1
10.3390/ijms24129903
10.1155/2021/9931742
10.3389/fnagi.2022.825086
10.1016/j.phrs.2019.104580
10.1186/s12974-020-1731-x
10.2991/efood.k.200203.001
10.1002/wsbm.1583
10.3389/fnins.2020.602508
10.1111/ene.14393
10.3390/polym15071596
10.3390/ph14010029
10.1007/s12035-016-0297-1
10.3748/wjg.v23.i30.5486
10.3390/ma14123332
10.1038/s41392-023-01588-0
10.3390/ijms21228421
10.1038/s41525-021-00243-3
10.3390/ijms23105744
10.3389/fimmu.2022.812774
10.3390/ph15020140
10.1007/978-1-4614-6434-1_174-1
10.3390/biomedicines11061752
10.3390/toxins5020363
10.3389/fnut.2023.1173660
10.3390/cells12151942
10.3389/fncel.2015.00278
10.7150/thno.83066
10.3389/fncel.2018.00329
10.1084/jem.20190945
10.1186/s41232-023-00277-3
10.1016/j.jmb.2019.01.045
10.1177/0271678X20951995
10.1039/D3RA03313A
10.1007/s10753-022-01730-0
10.3389/fncel.2016.00056
10.3390/molecules25204613
10.3390/cells12091231
10.3389/fimmu.2022.1088124
10.3389/fimmu.2019.01265
10.1016/j.nurt.2010.05.014
10.3389/fncel.2021.704884
10.3389/fcell.2021.751079
10.1016/j.neuron.2019.06.010
10.3390/ijms22168363
10.3390/biomedicines6030091
10.4103/1673-5374.306064
10.2147/IJN.S357598
10.3390/ijms23179583
10.18632/oncotarget.23208
10.7150/jca.47022
10.3233/JPD-223278
10.3390/ijms22042153
10.3390/ijms24010604
10.14802/jmd.22141
10.3389/fnmol.2019.00258
10.3389/fphar.2020.00356
10.1111/jnc.13607
10.3390/metabo12111064
10.3389/fnagi.2023.1145241
10.3233/JAD-151013
10.3389/fneur.2023.1103416
10.1186/s12964-017-0177-y
10.5056/jnm18087
10.3389/fimmu.2021.667705
10.3390/biomedicines9050524
10.1186/s40035-021-00271-0
10.1007/s12264-022-00981-z
10.3390/ijms23031851
ContentType Journal Article
Copyright Copyright © 2024 Adamu, Li, Gao and Xue.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright © 2024 Adamu, Li, Gao and Xue.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
DOA
DOI 10.3389/fnagi.2024.1347987
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed

MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1663-4365
ExternalDocumentID oai_doaj_org_article_2c343e6f023c4bb6baff89cc61c6a68c
38681666
10_3389_fnagi_2024_1347987
Genre Journal Article
Review
GroupedDBID ---
53G
5VS
7X7
88I
8FE
8FH
8FI
8FJ
9T4
AAFWJ
AAYXX
ABIVO
ABUWG
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
DWQXO
E3Z
EIHBH
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
KQ8
LK8
M2P
M48
M7P
M~E
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
TR2
UKHRP
IAO
IEA
IHR
IHW
IPNFZ
IPY
NPM
RIG
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQGLB
PQUKI
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c441t-71f29267e38ded180c4baa56c1714504c7d248385f1837906a1844eb2a8ee78e3
IEDL.DBID M48
ISSN 1663-4365
IngestDate Wed Aug 27 01:31:49 EDT 2025
Fri Jul 11 00:12:26 EDT 2025
Fri Jul 25 11:42:48 EDT 2025
Thu Jan 02 22:39:04 EST 2025
Thu Apr 24 22:56:58 EDT 2025
Tue Jul 01 02:20:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords neurodegenerative disease
Alzheimer’s disease
neuroinflammation
Parkinson’s disease
central nervous system
Language English
License Copyright © 2024 Adamu, Li, Gao and Xue.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-71f29267e38ded180c4baa56c1714504c7d248385f1837906a1844eb2a8ee78e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/3037199703?pq-origsite=%requestingapplication%
PMID 38681666
PQID 3037199703
PQPubID 4424411
ParticipantIDs doaj_primary_oai_doaj_org_article_2c343e6f023c4bb6baff89cc61c6a68c
proquest_miscellaneous_3048494522
proquest_journals_3037199703
pubmed_primary_38681666
crossref_primary_10_3389_fnagi_2024_1347987
crossref_citationtrail_10_3389_fnagi_2024_1347987
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-04-12
PublicationDateYYYYMMDD 2024-04-12
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-12
  day: 12
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Lausanne
PublicationTitle Frontiers in aging neuroscience
PublicationTitleAlternate Front Aging Neurosci
PublicationYear 2024
Publisher Frontiers Research Foundation
Frontiers Media S.A
Publisher_xml – name: Frontiers Research Foundation
– name: Frontiers Media S.A
References Griciuc (B39) 2019; 103
Chen (B15) 2021; 9
Khatoon (B60) 2023; 15
Lotfi (B70) 2019; 10
Ben Haim (B5) 2015; 9
Gao (B32) 2023; 8
Chen (B16) 2018; 9
Pajares (B86) 2020; 9
Deming (B22) 2018; 22
Yusuf (B125) 2023; 15
Griffioen (B40) 2018; 4
Cho (B19) 2020; 14
Sharma (B104) 2017
Dhaiban (B23) 2021; 3
Stefanis (B112) 2012; 2
Sever (B102) 2022; 23
Li (B68) 2020; 132
Mir Najib Ullah (B81) 2023; 11
Pasko (B90) 2022; 24
Radandish (B93) 2021; 12
Li (B67) 2003; 23
Konsman (B63) 2022; 15
Klann (B62) 2021; 13
Spiteri (B111) 2022; 143
Saleh (B98) 2022; 12
Zhang (B130) 2007; 45
Maghazachi (B73) 2013; 5
Burns (B10) 2023; 8
Mey (B80) 2023; 15
Cha (B13) 2023; 16
Turner (B116) 2016; 10
Holbrook (B48) 2021; 12
Papiri (B89) 2023; 45
Marogianni (B74) 2020; 21
Machado (B72) 2019; 71
Xu (B121) 2022; 17
Lamptey (B66) 2022; 23
Wilton (B119) 2020; 143
DiSabato (B26) 2016; 139
Mohandas (B82) 2009; 51
McQuade (B77) 2019; 431
Salehi (B99) 2018; 6
Kim (B61) 2021; 22
Gómez-Benito (B36) 2020; 11
Kanashiro (B54) 2020; 151
Ochocka (B84) 2021; 22
Kandpal (B55) 2022; 12
Zarrin (B128) 2021; 20
Harry (B45) 2008; 4
Fiebich (B31) 2018; 12
Gorecki (B37) 2021; 10
Palanisamy (B87) 2023; 13
Sharma (B105) 2023; 46
Ghasemi (B34) 2017; 19
Sharma (B106) 2021; 18
Sochocka (B110) 2017; 54
Hernández (B46) 2021; 2021
Mejzini (B78) 2019; 13
Rittiner (B95) 2020; 13
Ege (B29) 2021; 14
Shao (B103) 2022; 14
Sobue (B109) 2023; 43
Wang (B118) 2022; 11
Zahid (B126) 2019; 10
Gąssowska-Dobrowolska (B33) 2023; 24
Liu (B69) 2020; 21
Sivandzade (B108) 2021; 22
Turner (B115) 2014; 1843
Boros (B9) 2022; 19
Zhang (B132) 2023; 12
Paul (B91) 2021; 44
Blyufer (B8) 2021; 59
Mazzotta (B76) 2023; 12
Satarker (B100) 2022; 11
Aboudounya (B2) 2021; 2021
Guo (B42) 2021; 2021
Jung (B53) 2019; 7
Zang (B127) 2022; 14
Kennedy (B58) 2015
Diz-Chaves (B27) 2022; 23
Ansari (B4) 2023; 10
You (B124) 2023; 12
Han (B44) 2023; 39
Kwon (B65) 2020; 9
Abdelhamid (B1) 2022; 85
Qin (B92) 2023; 14
Zhang (B133) 2023; 51
Walton (B117) 2020; 26
Shen (B107) 2021; 13
Dilliott (B24) 2021; 6
Wu (B120) 2022; 2022
Kowalski (B64) 2019; 25
Gorji (B38) 2022; 23
Jia (B52) 2022; 13
Jain (B51) 2023; 15
Rivas-Fuentes (B96) 2021; 12
Cabeza-Cabrerizo (B11) 2021; 39
Hamilton (B43) 2020; 217
Chen (B17) 2023; 8
Tong (B114) 2016; 51
Sun (B113) 2023; 12
Hu (B49) 2023; 39
Lull (B71) 2010; 7
Kempuraj (B57) 2017; 11
Khan (B59) 2020; 1
Conte (B21) 2023; 12
Kanvinde (B56) 2022; 11
Yang (B122) 2020; 25
Yang (B123) 2020; 17
Masrori (B75) 2020; 27
Mortada (B83) 2021; 12
Giovannoni (B35) 2020; 41
Guo (B41) 2022; 14
Chen (B18) 2020; 10
Zhang (B129) 2021; 15
Clayton (B20) 2017; 11
Ronaldson (B97) 2020; 40
Chang (B14) 2017; 9
Fakhri (B30) 2022; 17
Bernardi (B6) 2012; 7
Ding (B25) 2021; 16
Reid (B94) 2021; 15
Biehl (B7) 2009; 24
Zhang (B131) 2023; 8
Ahmadi (B3) 2022; 13
Cenit (B12) 2017; 23
Meng (B79) 2023; 13
Palpagama (B88) 2019; 12
Seif (B101) 2017; 15
Duan (B28) 2022; 13
Zhou (B134) 2020; 14
Hung (B50) 2017; 24
Hol (B47) 2015; 32
Onyango (B85) 2021; 9
References_xml – volume: 59
  year: 2021
  ident: B8
  article-title: Riluzole: A neuroprotective drug with potential as a novel anti-cancer agent (Review).
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2021.5275
– volume: 4
  start-page: 1265
  year: 2008
  ident: B45
  article-title: Neuroinflammation and microglia: Considerations and approaches for neurotoxicity assessment.
  publication-title: Expert Opin. Drug Metab. Toxicol.
  doi: 10.1517/17425255.4.10.1265
– volume: 51
  start-page: 55
  year: 2009
  ident: B82
  article-title: Neurobiology of Alzheimer’s disease.
  publication-title: Indian J. Psychiatry
  doi: 10.4103/0019-5545.44908
– volume: 15
  year: 2021
  ident: B129
  article-title: Microglia in Alzheimer’s disease: A target for therapeutic intervention.
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2021.749587
– volume: 19
  start-page: 1145
  year: 2022
  ident: B9
  article-title: Antisense oligonucleotides for the study and treatment of ALS.
  publication-title: Neurotherapeutics
  doi: 10.1007/s13311-022-01247-2
– volume: 12
  year: 2023
  ident: B21
  article-title: Toll-like receptor 4 is upregulated in Parkinson’s Disease patients and co-localizes with pSer129αSyn: A possible link with the pathology.
  publication-title: Cells
  doi: 10.3390/cells12101368
– volume: 3
  year: 2021
  ident: B23
  article-title: Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
  publication-title: Science
  doi: 10.3390/sci3010012
– volume: 9
  year: 2020
  ident: B65
  article-title: Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes.
  publication-title: Transl. Neurodegen.
  doi: 10.1186/s40035-020-00221-2
– volume: 143
  year: 2020
  ident: B119
  article-title: The contribution of glial cells to Huntington’s disease pathogenesis.
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2020.104963
– volume: 14
  year: 2022
  ident: B127
  article-title: The emerging role of central and peripheral immune systems in neurodegenerative diseases.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2022.872134
– volume: 11
  year: 2017
  ident: B57
  article-title: Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration.
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2017.00216
– volume: 23
  start-page: 1605
  year: 2003
  ident: B67
  article-title: Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-05-01605.2003
– volume: 26
  start-page: 1816
  year: 2020
  ident: B117
  article-title: Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
  publication-title: Mult. Scler.
  doi: 10.1177/1352458520970841
– volume: 13
  year: 2021
  ident: B62
  article-title: The gut-brain axis and its relation to Parkinson’s Disease: A review.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.782082
– volume: 9
  year: 2017
  ident: B14
  article-title: Tumor necrosis factor α Inhibition for Alzheimer’s Disease.
  publication-title: J. Cent. Nerv. Syst. Dis.
  doi: 10.1177/1179573517709278
– volume: 8
  year: 2023
  ident: B131
  article-title: Role of neuroinflammation in neurodegeneration development.
  publication-title: Sig. Transduct. Target Ther.
  doi: 10.1038/s41392-023-01486-5
– volume: 2
  year: 2012
  ident: B112
  article-title: α-Synuclein in Parkinson’s disease.
  publication-title: Cold Spring Harb. Perspect. Med.
  doi: 10.1101/cshperspect.a009399
– volume: 41
  start-page: 805
  year: 2020
  ident: B35
  article-title: The role of astrocytes in CNS inflammation.
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2020.07.007
– volume: 2021
  year: 2021
  ident: B2
  article-title: COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation.
  publication-title: Mediat. Inflamm.
  doi: 10.1155/2021/8874339
– volume: 7
  start-page: 4927
  year: 2012
  ident: B6
  article-title: Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer’s disease models.
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S35333
– volume: 45
  start-page: 27
  year: 2007
  ident: B130
  article-title: Cytokines, inflammation, and pain.
  publication-title: Int. Anesthesiol. Clin.
  doi: 10.1097/AIA.0b013e318034194e
– volume: 8
  start-page: 42045
  year: 2023
  ident: B10
  article-title: Nanophytomedicines as therapeutic agents for Parkinson’s Disease.
  publication-title: ACS Omega
  doi: 10.1021/acsomega.3c04862
– volume: 22
  year: 2021
  ident: B84
  article-title: Microglia diversity in healthy and diseased brain: Insights from single-cell omics.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22063027
– volume: 51
  year: 2023
  ident: B133
  article-title: PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis.
  publication-title: J. Int. Med. Res.
  doi: 10.1177/03000605231177191
– volume: 22
  start-page: 587
  year: 2018
  ident: B22
  article-title: Triggering receptor expressed on myeloid cells 2 (TREM2): A potential therapeutic target for Alzheimer disease?
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1080/14728222.2018.1486823
– volume: 12
  year: 2021
  ident: B48
  article-title: Neurodegenerative Disease and the NLRP3 Inflammasome.
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.643254
– volume: 1843
  start-page: 2563
  year: 2014
  ident: B115
  article-title: Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.
  publication-title: Biochim Biophys Acta Mol Cell Res.
  doi: 10.1016/j.bbamcr.2014.05.014
– volume: 44
  start-page: 83
  year: 2021
  ident: B91
  article-title: Signaling by cGAS–STING in neurodegeneration, neuroinflammation, and aging.
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2020.10.008
– volume: 24
  year: 2017
  ident: B50
  article-title: Drug candidates in clinical trials for Alzheimer’s disease.
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-017-0355-7
– volume: 132
  year: 2020
  ident: B68
  article-title: Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease.
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2020.110887
– volume: 45
  start-page: 1443
  year: 2023
  ident: B89
  article-title: Multiple sclerosis: Inflammatory and neuroglial aspects.
  publication-title: CIMB
  doi: 10.3390/cimb45020094
– volume: 10
  start-page: 1347
  year: 2020
  ident: B18
  article-title: Gene therapy for neurodegenerative disorders: Advances, insights and prospects.
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2020.01.015
– volume: 11
  year: 2022
  ident: B100
  article-title: Astrocytic glutamatergic transmission and its implications in neurodegenerative disorders.
  publication-title: Cells
  doi: 10.3390/cells11071139
– volume: 23
  year: 2022
  ident: B102
  article-title: Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23052400
– volume: 20
  start-page: 39
  year: 2021
  ident: B128
  article-title: Kinase inhibition in autoimmunity and inflammation.
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-020-0082-8
– volume: 7
  year: 2019
  ident: B53
  article-title: Neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments.
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2019.00313
– volume: 4
  year: 2018
  ident: B40
  article-title: Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington’s disease mice.
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2018.e00508
– volume: 9
  year: 2020
  ident: B86
  article-title: Inflammation in Parkinson’s Disease: Mechanisms and therapeutic implications.
  publication-title: Cells
  doi: 10.3390/cells9071687
– volume: 39
  start-page: 832
  year: 2023
  ident: B44
  article-title: NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson’s Disease.
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-023-01023-y
– volume: 2022
  year: 2022
  ident: B120
  article-title: Toll-like receptor 4: A promising therapeutic target for Alzheimer’s Disease.
  publication-title: Mediat. Inflamm.
  doi: 10.1155/2022/7924199
– volume: 32
  start-page: 121
  year: 2015
  ident: B47
  article-title: Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system.
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2015.02.004
– volume: 21
  year: 2020
  ident: B69
  article-title: Stem cell-based therapies for Parkinson Disease.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21218060
– volume: 13
  year: 2019
  ident: B78
  article-title: ALS genetics, mechanisms, and therapeutics: Where are we now?
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.01310
– volume: 10
  year: 2019
  ident: B126
  article-title: Pharmacological Inhibitors of the NLRP3 inflammasome.
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.02538
– volume: 24
  start-page: 98
  year: 2009
  ident: B7
  article-title: Introduction to Stem Cell Therapy.
  publication-title: J. Cardiovasc. Nurs.
  doi: 10.1097/JCN.0b013e318197a6a5
– volume: 17
  start-page: 299
  year: 2022
  ident: B30
  article-title: Nanoparticles in combating neuronal dysregulated signaling pathways: Recent approaches to the nanoformulations of phytochemicals and synthetic drugs against neurodegenerative diseases.
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S347187
– volume: 39
  start-page: 131
  year: 2021
  ident: B11
  article-title: Dendritic cells revisited.
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-061020-053707
– volume: 13
  start-page: 471
  year: 2022
  ident: B3
  article-title: Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors.
  publication-title: RSC Med. Chem.
  doi: 10.1039/d1md00280e
– volume: 143
  start-page: 179
  year: 2022
  ident: B111
  article-title: Microglia and monocytes in inflammatory CNS disease: Integrating phenotype and function.
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-021-02384-2
– volume: 12
  year: 2023
  ident: B132
  article-title: Parkinson’s disease and gut microbiota: From clinical to mechanistic and therapeutic studies.
  publication-title: Transl. Neurodegen.
  doi: 10.1186/s40035-023-00392-8
– volume: 2021
  year: 2021
  ident: B46
  article-title: Mesenchymal stem cell therapy for Alzheimer’s Disease.
  publication-title: Stem Cells Int.
  doi: 10.1155/2021/7834421
– volume: 14
  year: 2022
  ident: B41
  article-title: Microglia polarization from M1 to M2 in neurodegenerative diseases.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2022.815347
– volume: 11
  year: 2022
  ident: B56
  article-title: Non-viral vectors for delivery of nucleic acid therapies for cancer.
  publication-title: BioTech
  doi: 10.3390/biotech11010006
– volume: 71
  start-page: 556
  year: 2019
  ident: B72
  article-title: PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease.
  publication-title: Pharmacol. Rep.
  doi: 10.1016/j.pharep.2018.11.005
– volume: 15
  year: 2023
  ident: B51
  article-title: The role of gut microbiota in neurodegenerative diseases: Current insights and therapeutic implications.
  publication-title: Cureus
  doi: 10.7759/cureus.47861
– volume: 13
  year: 2020
  ident: B95
  article-title: Gene-editing technologies paired with viral vectors for translational research into neurodegenerative diseases.
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2020.00148
– volume: 12
  year: 2021
  ident: B83
  article-title: Immunotherapies for neurodegenerative diseases.
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2021.654739
– volume: 11
  year: 2022
  ident: B118
  article-title: New insights into the gut microbiota in neurodegenerative diseases from the perspective of redox homeostasis.
  publication-title: Antioxidants
  doi: 10.3390/antiox11112287
– volume: 11
  year: 2017
  ident: B20
  article-title: Alzheimer’s Disease: The role of microglia in brain homeostasis and proteopathy.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2017.00680
– volume: 12
  year: 2023
  ident: B124
  article-title: Microglia and astrocytes in amyotrophic lateral sclerosis: Disease-associated states, pathological roles, and therapeutic potential.
  publication-title: Biology
  doi: 10.3390/biology12101307
– year: 2017
  ident: B104
  article-title: Stem cell therapy in pediatric neurological disabilities
  publication-title: Physical Disabilities - Therapeutic Implications
  doi: 10.5772/67656
– volume: 85
  start-page: 1555
  year: 2022
  ident: B1
  article-title: Probiotic Bifidobacterium breve prevents memory impairment through the reduction of both amyloid-β production and microglia activation in APP knock-in mouse.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-215025
– volume: 8
  year: 2023
  ident: B17
  article-title: Macrophages in immunoregulation and therapeutics.
  publication-title: Sig. Transduct. Target Ther.
  doi: 10.1038/s41392-023-01452-1
– volume: 13
  year: 2021
  ident: B107
  article-title: The association between the gut microbiota and parkinson’s disease, a meta-analysis.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.636545
– volume: 18
  year: 2021
  ident: B106
  article-title: A systemic immune challenge to model hospital-acquired infections independently regulates immune responses after pediatric traumatic brain injury.
  publication-title: J. Neuroinflamm.
  doi: 10.1186/s12974-021-02114-1
– volume: 24
  year: 2023
  ident: B33
  article-title: Microglia and astroglia-the potential role in neuroinflammation induced by pre- and neonatal exposure to lead (Pb).
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms24129903
– volume: 19
  start-page: 1
  year: 2017
  ident: B34
  article-title: Multiple sclerosis: Pathogenesis. Symptoms, diagnoses and cell-based therapy
  publication-title: Cell J.
– volume: 2021
  year: 2021
  ident: B42
  article-title: The role of neutrophil extracellular traps in central nervous system diseases and prospects for clinical application.
  publication-title: Oxid. Med. Cell Longev.
  doi: 10.1155/2021/9931742
– volume: 14
  year: 2022
  ident: B103
  article-title: Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2022.825086
– volume: 151
  year: 2020
  ident: B54
  article-title: The role of neutrophils in neuro-immune modulation.
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2019.104580
– volume: 17
  year: 2020
  ident: B123
  article-title: Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.
  publication-title: J. Neuroinflamm.
  doi: 10.1186/s12974-020-1731-x
– volume: 1
  start-page: 38
  year: 2020
  ident: B59
  article-title: Dietary flavonoids in the management of Huntington’s Disease: Mechanism and clinical perspective.
  publication-title: eFood
  doi: 10.2991/efood.k.200203.001
– volume: 15
  year: 2023
  ident: B80
  article-title: Neurodegeneration in multiple sclerosis.
  publication-title: WIREs Mech. Dis.
  doi: 10.1002/wsbm.1583
– volume: 14
  year: 2020
  ident: B134
  article-title: TLR4 targeting as a promising therapeutic strategy for Alzheimer disease treatment.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2020.602508
– volume: 27
  start-page: 1918
  year: 2020
  ident: B75
  article-title: Amyotrophic lateral sclerosis: A clinical review.
  publication-title: Eur. J. Neurol.
  doi: 10.1111/ene.14393
– volume: 15
  year: 2023
  ident: B125
  article-title: Nanoparticles as drug delivery systems: A review of the implication of nanoparticles’ physicochemical properties on responses in biological systems.
  publication-title: Polymers
  doi: 10.3390/polym15071596
– volume: 14
  year: 2020
  ident: B19
  article-title: Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis.
  publication-title: Pharmaceuticals
  doi: 10.3390/ph14010029
– volume: 54
  start-page: 8071
  year: 2017
  ident: B110
  article-title: Inflammatory response in the CNS: Friend or Foe?
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-016-0297-1
– volume: 23
  start-page: 5486
  year: 2017
  ident: B12
  article-title: Influence of gut microbiota on neuropsychiatric disorders.
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v23.i30.5486
– volume: 14
  year: 2021
  ident: B29
  article-title: Action mechanisms of curcumin in Alzheimer’s disease and its brain targeted delivery.
  publication-title: Materials
  doi: 10.3390/ma14123332
– volume: 8
  year: 2023
  ident: B32
  article-title: Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets.
  publication-title: Sig. Transduct. Target Ther.
  doi: 10.1038/s41392-023-01588-0
– volume: 21
  year: 2020
  ident: B74
  article-title: Neurodegeneration and inflammation-an interesting interplay in Parkinson’s Disease.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21228421
– volume: 6
  year: 2021
  ident: B24
  article-title: Contribution of rare variant associations to neurodegenerative disease presentation.
  publication-title: npj Genom. Med.
  doi: 10.1038/s41525-021-00243-3
– volume: 23
  year: 2022
  ident: B38
  article-title: Neuroinflammation: The pathogenic mechanism of neurological disorders.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23105744
– volume: 13
  year: 2022
  ident: B28
  article-title: Toll-like receptor signaling and its role in cell-mediated immunity.
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.812774
– volume: 15
  year: 2022
  ident: B63
  article-title: Cytokines in the brain and neuroinflammation: We didn’t starve the fire!
  publication-title: Pharmaceuticals
  doi: 10.3390/ph15020140
– start-page: 1
  year: 2015
  ident: B58
  article-title: Neuroimmune signaling: Cytokines and the CNS
  publication-title: Neuroscience in the 21st Century
  doi: 10.1007/978-1-4614-6434-1_174-1
– volume: 11
  year: 2023
  ident: B81
  article-title: Nanomedicine in the management of Alzheimer’s Disease: State-of-the-art.
  publication-title: Biomedicines
  doi: 10.3390/biomedicines11061752
– volume: 5
  start-page: 363
  year: 2013
  ident: B73
  article-title: On the role of natural killer cells in neurodegenerative diseases.
  publication-title: Toxins
  doi: 10.3390/toxins5020363
– volume: 10
  year: 2023
  ident: B4
  article-title: The role of probiotics and prebiotics in modulating of the gut-brain axis.
  publication-title: Front. Nutr.
  doi: 10.3389/fnut.2023.1173660
– volume: 12
  year: 2023
  ident: B113
  article-title: Microglia-astrocyte interaction in neural development and neural pathogenesis.
  publication-title: Cells
  doi: 10.3390/cells12151942
– volume: 9
  year: 2015
  ident: B5
  article-title: Elusive roles for reactive astrocytes in neurodegenerative diseases.
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2015.00278
– volume: 13
  start-page: 4138
  year: 2023
  ident: B87
  article-title: New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs).
  publication-title: Theranostics
  doi: 10.7150/thno.83066
– volume: 12
  year: 2018
  ident: B31
  article-title: Role of microglia TLRs in neurodegeneration.
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2018.00329
– volume: 217
  year: 2020
  ident: B43
  article-title: GM-CSF in inflammation.
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20190945
– volume: 43
  year: 2023
  ident: B109
  article-title: Neuroinflammation in Alzheimer’s disease: Microglial signature and their relevance to disease.
  publication-title: Inflamm. Regen.
  doi: 10.1186/s41232-023-00277-3
– volume: 431
  start-page: 1805
  year: 2019
  ident: B77
  article-title: Microglia in Alzheimer’s Disease: Exploring how genetics and phenotype influence risk.
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2019.01.045
– volume: 40
  start-page: S6
  year: 2020
  ident: B97
  article-title: Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1177/0271678X20951995
– volume: 13
  start-page: 20476
  year: 2023
  ident: B79
  article-title: Recent advances in small molecules for improving mitochondrial disorders.
  publication-title: RSC Adv.
  doi: 10.1039/D3RA03313A
– volume: 46
  start-page: 56
  year: 2023
  ident: B105
  article-title: Role of NLRP3 inflammasome and its inhibitors as emerging therapeutic drug candidate for Alzheimer’s disease: A review of mechanism of activation.
  publication-title: Regul. Inhibit. Inflamm.
  doi: 10.1007/s10753-022-01730-0
– volume: 10
  year: 2016
  ident: B116
  article-title: Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke.
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2016.00056
– volume: 25
  year: 2020
  ident: B122
  article-title: Nanoformulations to enhance the bioavailability and physiological functions of polyphenols.
  publication-title: Molecules
  doi: 10.3390/molecules25204613
– volume: 12
  year: 2023
  ident: B76
  article-title: Synucleinopathies take their toll: Are TLRs a way to go?
  publication-title: Cells
  doi: 10.3390/cells12091231
– volume: 13
  year: 2022
  ident: B52
  article-title: Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics.
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.1088124
– volume: 10
  year: 2019
  ident: B70
  article-title: Roles of GM-CSF in the pathogenesis of autoimmune diseases: An update.
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01265
– volume: 7
  start-page: 354
  year: 2010
  ident: B71
  article-title: Microglial activation and chronic neurodegeneration.
  publication-title: Neurotherapeutics
  doi: 10.1016/j.nurt.2010.05.014
– volume: 15
  year: 2021
  ident: B94
  article-title: She doesn’t even go here: The role of inflammatory astrocytes in CNS disorders.
  publication-title: Front. Cell Neurosci.
  doi: 10.3389/fncel.2021.704884
– volume: 9
  year: 2021
  ident: B15
  article-title: Exosomes, a New star for targeted delivery.
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2021.751079
– volume: 103
  start-page: 820
  year: 2019
  ident: B39
  article-title: TREM2 Acts downstream of CD33 in modulating microglial pathology in Alzheimer’s Disease.
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.06.010
– volume: 22
  year: 2021
  ident: B61
  article-title: New avenues for the treatment of Huntington’s Disease.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22168363
– volume: 6
  year: 2018
  ident: B99
  article-title: Resveratrol: A double-edged sword in health benefits.
  publication-title: Biomedicines
  doi: 10.3390/biomedicines6030091
– volume: 16
  start-page: 1702
  year: 2021
  ident: B25
  article-title: Astrocytes: A double-edged sword in neurodegenerative diseases.
  publication-title: Neural Regen. Res.
  doi: 10.4103/1673-5374.306064
– volume: 17
  start-page: 1927
  year: 2022
  ident: B121
  article-title: Nanomedicine: An emerging novel therapeutic strategy for hemorrhagic stroke.
  publication-title: IJN
  doi: 10.2147/IJN.S357598
– volume: 23
  year: 2022
  ident: B27
  article-title: Anti-Inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23179583
– volume: 9
  start-page: 7204
  year: 2018
  ident: B16
  article-title: Inflammatory responses and inflammation-associated diseases in organs.
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23208
– volume: 12
  start-page: 571
  year: 2021
  ident: B96
  article-title: Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review.
  publication-title: J. Cancer
  doi: 10.7150/jca.47022
– volume: 12
  start-page: S201
  year: 2022
  ident: B98
  article-title: Therapeutic strategies for immune transformation in Parkinson’s Disease.
  publication-title: J. Parkinsons Dis.
  doi: 10.3233/JPD-223278
– volume: 22
  year: 2021
  ident: B108
  article-title: Regenerative stem cell therapy for neurodegenerative diseases: An overview.
  publication-title: IJMS
  doi: 10.3390/ijms22042153
– volume: 24
  year: 2022
  ident: B90
  article-title: Modeling of neurodegenerative diseases: “Step by Step” and “Network” organization of the complexes of model systems.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms24010604
– volume: 16
  start-page: 22
  year: 2023
  ident: B13
  article-title: Current status and future perspectives on stem cell-based therapies for Parkinson’s Disease.
  publication-title: J. Mov. Disord.
  doi: 10.14802/jmd.22141
– volume: 12
  year: 2019
  ident: B88
  article-title: The role of microglia and astrocytes in Huntington’s disease.
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2019.00258
– volume: 11
  year: 2020
  ident: B36
  article-title: Modeling Parkinson’s disease with the alpha-synuclein protein.
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2020.00356
– volume: 139
  start-page: 136
  year: 2016
  ident: B26
  article-title: Neuroinflammation: The devil is in the details.
  publication-title: J. Neurochem.
  doi: 10.1111/jnc.13607
– volume: 12
  year: 2022
  ident: B55
  article-title: Dysbiosis of gut microbiota from the perspective of the gut-brain axis: Role in the provocation of neurological disorders.
  publication-title: Metabolites
  doi: 10.3390/metabo12111064
– volume: 15
  year: 2023
  ident: B60
  article-title: Effects of gut microbiota on neurodegenerative diseases.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2023.1145241
– volume: 51
  start-page: 123
  year: 2016
  ident: B114
  article-title: T3D-959: A multi-faceted disease remedial drug candidate for the treatment of Alzheimer’s Disease.
  publication-title: JAD
  doi: 10.3233/JAD-151013
– volume: 14
  year: 2023
  ident: B92
  article-title: Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts.
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2023.1103416
– volume: 15
  year: 2017
  ident: B101
  article-title: The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.
  publication-title: Cell Commun. Signal.
  doi: 10.1186/s12964-017-0177-y
– volume: 25
  start-page: 48
  year: 2019
  ident: B64
  article-title: Brain-gut-microbiota axis in Alzheimer’s Disease.
  publication-title: J. Neurogastroenterol. Motil.
  doi: 10.5056/jnm18087
– volume: 12
  year: 2021
  ident: B93
  article-title: The role of distinct subsets of macrophages in the pathogenesis of MS and the impact of different therapeutic agents on these populations.
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.667705
– volume: 9
  year: 2021
  ident: B85
  article-title: Neuroinflammation in Alzheimer’s Disease.
  publication-title: Biomedicines
  doi: 10.3390/biomedicines9050524
– volume: 10
  year: 2021
  ident: B37
  article-title: TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut.
  publication-title: Transl. Neurodegener.
  doi: 10.1186/s40035-021-00271-0
– volume: 39
  start-page: 541
  year: 2023
  ident: B49
  article-title: Interactions between astrocytes and oligodendroglia in myelin development and related brain diseases.
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-022-00981-z
– volume: 23
  year: 2022
  ident: B66
  article-title: Review of the common neurodegenerative disorders: Current therapeutic approaches and the potential role of nanotherapeutics.
  publication-title: IJMS
  doi: 10.3390/ijms23031851
SSID ssj0000330058
Score 2.6216905
SecondaryResourceType review_article
Snippet Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and...
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 1347987
SubjectTerms Alzheimer's disease
Amyotrophic lateral sclerosis
Brain research
Cell therapy
Central nervous system
Chemokines
Chronic illnesses
Cytokines
Disease
Glial cells
Immune response
Immune response (cell-mediated)
Immune system
Infections
Inflammation
Injuries
Movement disorders
Multiple sclerosis
Nanoparticles
Neurodegeneration
neurodegenerative disease
Neurodegenerative diseases
neuroinflammation
Neurological disorders
Neuronal-glial interactions
Parkinson's disease
Reactive nitrogen species
Reactive oxygen species
Therapeutic targets
Trauma
Viral infections
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS8MwEA_ig_gifludEsE3qWubNEl9U3EMYT452FtoskQE6dRt_793STf6or74VEivkN5d7nLc3e8IuSqlYbxkJuVKsBQBydOqKstUGVAWZcBoSmxwHj2L4Zg_TcpJZ9QX1oRFeODIuH5hGWdOePAtlhsjTO29qqwVuRW1UBatL_i8TjAVbDBDGHYVu2QgCqv6Hqf-QDxY8JvQPYk1dB1PFAD7f75lBm8z2CU77TWR3sXt7ZEN1-yTrVGbCD8gnyBeipWBdOZpwKQETQHhxkZE-tbExal7DbDSaNNom4uZ31IbQZnostvZQuFBI8QI7XRl0VgrPj8k48Hjy8MwbacnpBauOItU5r6oCiEdU1M3zVUG7KvrUlgceV5m3MppwRVTpYdTLatM1BDscQi0a-WcVI4dkc1m1rgTQr3JfM48JhErROxT3knPPLOOA2EhE5KvOKltCy2OEy7eNYQYyH0duK-R-7rlfkKu1998RGCNX6nvUUBrSgTFDgugKrpVFf2XqiSktxKvbk_qXKM2YrFNxhJyuX4NZwwTJ3XjZkuk4YpXiD2fkOOoFuudMCVC6vX0P3Z4Rrbxr9OAJdkjm4uvpTuHS8_CXAT9_gaKnP-r
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Na90wDDdbB2OX0q5bm7UdHuxWvCbxZ3YZa1kpg-60wruZ2LHLoCRt33v__yTbL3uX9RRw7BBLsi1Z0k-EfJbacSG5Y8IozhCQnHWdlMw4EBbjYNPUmOB880td34qfC7koF27LEla52RPTRj1MHu_Iz3EUBkXU_NvDI8OqUehdLSU0XpJXCF2GUq0Xer5jqTmCsadsOIV_wpXMeTNgl3XnEesAgYXYii8pnxKj6rbOpgTh_3-9M50_V3tktyiO9Hvm9D55Eca35PVNcY0fkEdgOMVYQTpFmlAqQXaA3Tk1kf4Zc-MQ7hLQNO5ytHhnll-pzzBNdL2d60LhQTPoCN3K06I5enz5jtxe_fh9ec1KPQXmQelZMd3EtmuVDtwMYWhM7YXre6k8FkGXtfB6aIXhRkZY57qrVQ_mnwDTuzchaBP4e7IzTmM4IjS6OjY8oluxQww_E4OOPHIfBHRsdUWaDSWtL2DjWPPi3oLRgdS3ifoWqW8L9StyNo95yFAbz_a-QAbNPREmOzVMT3e2rDrbei54UBEUE5irU66P0XTeq8arXhlfkZMNe21Zu0v7T9Iq8ml-DasOXSn9GKY19hFGdIhGX5HDLBbzn3CjkjP2w_MfPyZvcD4s4UaekJ3V0zqcgoKzch-TFP8Fbez33Q
  priority: 102
  providerName: ProQuest
Title The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
URI https://www.ncbi.nlm.nih.gov/pubmed/38681666
https://www.proquest.com/docview/3037199703
https://www.proquest.com/docview/3048494522
https://doaj.org/article/2c343e6f023c4bb6baff89cc61c6a68c
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3raxQxEB_6APGL-Ha1HhH8Jlt3N88VRKy0FuGKiAf3LWxySSmUPXsPaP97Z5K9o4IVv-zC7mRJZibJzE7mNwBvpXZcSO5KYRQvCZC8bFspS-NQWYzDRVNTgvP4TJ1OxLepnO7AptzRwMDlX107qic1WVweXl_dfMIJ_5E8Ttxv30cq6IOuXiMOU2Kk0buwjzuTpooG48HcTyszJ3D2lB2nqGdcyZxHc8dn_tirEqT_3XZo2o9OHsKDwZBkn7PkH8FO6B_DvfEQKn8CV6gAjM4OsnlkCbUSR4fiz6mK7KLPD2fhPAFP06rHhmjN8gPzGbaJrW_nvjC8sQxCwm7lbbF8mnz5FCYnxz-_nJZDfYXSoxG0KnUdm7ZROnAzC7PaVF64rpPKU1F0WQmvZ40w3MiI8163lerQHRToincmBG0CfwZ7_bwPL4BFV8WaRwoztoTpZ2LQkUfug0DCRhdQbzhp_QA-TjUwLi06IcR9m7hvift24H4B77ZtfmXojX9SH5GAtpQEm50ezBfndpiFtvFc8KAiGio4VqdcF6NpvVe1V50yvoCDjXjtRhUt6Ssdx6l4AW-2r3EWUmil68N8TTTCiJbQ6Qt4ntVi2xNuVArOvvyP1q_gPg2qTGCSB7C3WqzDa7R6Vm4Eu3qqR7B_dHz2_cco_TvA69dpPUpK_huRVAJk
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJtAASPBCYUmsWM7SAjxqra021Mr7c0kjl0hoaTt7grxp_iNzNhJ2Au99RQpcaJ4_Hns8cx8A_CqVA0XJW9SoSVPiZA8raqyTHWDYNENKk1FCc7zIzk7Ed8W5WIL_oy5MBRWOerEoKjb3tIZ-S69RUERGf9wdp5S1Sjyro4lNCIsDtzvX2iyLd_vf8HxfV0Ue1-PP8_SoapAanHpX6Uq90VVSOW4bl2b68yKpq5LaakUeJkJq9pCaK5Lj2hXVSZrNIIEGqC1dk5px_G71-A6LrwZGXtqoaYznYwT-XvIvpPUcy7LmKeDdmC166nuEFqkhXgb8jcpim9jLQwlA_6_zw3r3d4duD1sVNnHiKy7sOW6e3BjPrji78M5AoxRbCLrPQusmIhVhFdMhWQ_unizdaeB2Jq0Khu8Qct3zEZaKLbezK1heGGR5IRt5IWxGK2-fAAnVyLph7Dd9Z17DMw3mc-5JzdmRZyB2jvluefWCWxYqATyUZLGDuTmVGPjp0Ejh6RvgvQNSd8M0k_gzfTOWaT2uLT1JxqgqSXRcocb_cWpGWa5KSwX3EmPGyHsayOb2ntdWStzK2upbQI74_CaQVcszT9kJ_ByeoyznFw3def6NbURWlTEfp_AowiL6U-4lsH5--Tyj7-Am7Pj-aE53D86eAq3qG9p4Kzcge3Vxdo9w83VqnkeEM3g-1VPob8CLDMh
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQbwJFDASnFDYJHZsBwkhSrtqKV1ViEq9uYljV0goabu7Qvw1fh0zzoO90FtPkRInSsafJzOemW8AXueq4iLnVSy05DERksdFkeexrhAsukKlqajA-Wgu90_El9P8dAP-DLUwlFY56MSgqOvW0h75lO6ipIiET32fFnG8O_t4cRlTBymKtA7tNDqIHLrfv9B9W3w42MW5fpNls73vn_fjvsNAbNEMWMYq9VmRSeW4rl2d6sSKqixzaakteJ4Iq-pMaK5zj8hXRSJLdIgEOqOldk5px_G5t2BTkVc0gc2dvfnxt3GHJ-FEBR9q8STJgcu8q9pBr7CYeupChP5pJt6Fak7K6Vv7M4YGAv-3esPfb3YX7vRmK_vU4ewebLjmPmwd9YH5B3CJcGOUqchazwJHJiIXwdYVRrIfTXeydueB5pp0LOtjQ4v3zHYkUWy1XmnD8MA6yhO2ViXGutz1xUM4uRFZP4JJ0zbuCTBfJT7lnoKaBTEIau-U555bJ3BgpiJIB0ka21OdU8eNnwZdHpK-CdI3JH3TSz-Ct-M9Fx3Rx7Wjd2iCxpFE0h1OtFfnpl_zJrNccCc9mkX4rZWsSu91Ya1MrSylthFsD9Nres2xMP9wHsGr8TKueQrklI1rVzRGaFEQF34EjztYjG_CtQyh4KfXP_wlbOHyMV8P5ofP4DZ9WhwILLdhsrxauedoaS2rFz2kGZzd9Cr6C6XmOLw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+neuroinflammation+in+neurodegenerative+diseases%3A+current+understanding+and+future+therapeutic+targets&rft.jtitle=Frontiers+in+aging+neuroscience&rft.au=Adamu%2C+Alhamdu&rft.au=Li%2C+Shuo&rft.au=Gao%2C+Fankai&rft.au=Xue%2C+Guofang&rft.date=2024-04-12&rft.issn=1663-4365&rft.eissn=1663-4365&rft.volume=16&rft.spage=1347987&rft_id=info:doi/10.3389%2Ffnagi.2024.1347987&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-4365&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-4365&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-4365&client=summon